Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarilumab for Non-Infectious Intermediate, Posterior or Pan-Uveitis
2012-004845-34Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jun 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Hyalitis, posterior uveitis and uveitis comparing Sarilumab with Placebo (2 arms). Started Jun 2013; status: completed.
02
Drugs
sarilumab
03
Conditions
Hyalitisposterior uveitisuveitis
Beyond the preview
Go deeper on 2012-004845-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004845-34.